Teva Pharmaceuticals joins forces with Honeywell for energy efficiency

financialexpress.com:

Teva Pharmaceuticals, a leading generic pharmaceutical company, is taking proactive measures to reduce its environmental impact by partnering with Honeywell, a technology company, to optimize energy consumption and carbon emissions at its manufacturing facility in Debrecen, Hungary.

Through Honeywell’s innovative ‘Energy as a Service’ (EaaS) model, Teva will be able to implement energy improvement upgrades without a significantcapital investment. This move aligns with Teva’s commitment to environmental, social, and governance goals, demonstrating its dedication to sustainability and responsible business practices.

Under the EaaS contract, Honeywell will establish a three-year energy performance baseline for the Debrecen facility, enabling them to identify the key drivers of energy consumption on-site. By utilizing Honeywell Forge Sustainability plus for Buildings | Carbon and Energy Management alongside submetering tools, Honeywell will continuously monitor energy use data at both the device and asset levels. This data-driven approach will help Honeywell and Teva collaborate on a comprehensive plan to reduce energy usage while ensuring an ideal occupant experience.

Gary Baker, General Manager of Teva Active Pharmaceutical Ingredients in Hungary, emphasized the company’s commitment to reducing its carbon impact as a responsibility, not just a commitment. Teva has already achieved significant progress in minimizing its environmental footprint. The company reported a 24 percent reduction in absolute scope 1 and 2 greenhouse gas emissions compared to 2019, putting them ahead of schedule to meet their 2025 target of a 25 percent reduction. Additionally, they reduced absolute scope 3 GHG emissions by 12 percent compared to